• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

基于磁共振成像的血管特征动态演变预测乳腺癌新辅助化疗的病理反应、复发模式和生存结果

Dynamic Evolution of Vascular Features Based on Magnetic Resonance Imaging to Predict Pathological Response, Patterns of Recurrence and Survival Outcomes in Breast Cancer Neoadjuvant Chemotherapy.

作者信息

Wu Qiong, Zhu Mingxi, Xie Huaying, Geng Xiaochuan, Wang Yan, Wu Ziping, Lin Yanping, Xu Shuguang, Ye Yumei, Yin Wenjin, Zhuang Zhiguo, Lu Jingsong, Zhou Liheng

机构信息

Department of Breast Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China.

Department of Radiation Oncology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China.

出版信息

Curr Oncol. 2025 Jun 13;32(6):350. doi: 10.3390/curroncol32060350.

DOI:10.3390/curroncol32060350
PMID:40558293
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12192275/
Abstract

Neoadjuvant chemotherapy (NAC), followed by surgery and adjuvant therapy, constitutes the prevailing therapeutic paradigm for patients with locally advanced breast cancer (LABC) [...].

摘要

新辅助化疗（NAC），随后进行手术和辅助治疗，是局部晚期乳腺癌（LABC）患者的主要治疗模式[……]。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ffa/12192275/22ecb2328ba8/curroncol-32-00350-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ffa/12192275/43d57d3b5ae3/curroncol-32-00350-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ffa/12192275/ce0c2c7ea40c/curroncol-32-00350-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ffa/12192275/40af7e352b61/curroncol-32-00350-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ffa/12192275/8d2520441fd0/curroncol-32-00350-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ffa/12192275/58115cde0c1f/curroncol-32-00350-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ffa/12192275/91d26f297e21/curroncol-32-00350-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ffa/12192275/22ecb2328ba8/curroncol-32-00350-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ffa/12192275/43d57d3b5ae3/curroncol-32-00350-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ffa/12192275/ce0c2c7ea40c/curroncol-32-00350-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ffa/12192275/40af7e352b61/curroncol-32-00350-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ffa/12192275/8d2520441fd0/curroncol-32-00350-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ffa/12192275/58115cde0c1f/curroncol-32-00350-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ffa/12192275/91d26f297e21/curroncol-32-00350-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ffa/12192275/22ecb2328ba8/curroncol-32-00350-g007.jpg

相似文献

1
Dynamic Evolution of Vascular Features Based on Magnetic Resonance Imaging to Predict Pathological Response, Patterns of Recurrence and Survival Outcomes in Breast Cancer Neoadjuvant Chemotherapy.基于磁共振成像的血管特征动态演变预测乳腺癌新辅助化疗的病理反应、复发模式和生存结果
Curr Oncol. 2025 Jun 13;32(6):350. doi: 10.3390/curroncol32060350.
2
Comparison of breast-conserving surgery with mastectomy in locally advanced breast cancer after good response to neoadjuvant chemotherapy: A PRISMA-compliant systematic review and meta-analysis.新辅助化疗取得良好反应后，局部晚期乳腺癌保乳手术与乳房切除术的比较：一项遵循PRISMA标准的系统评价和荟萃分析
Medicine (Baltimore). 2017 Oct;96(43):e8367. doi: 10.1097/MD.0000000000008367.
3
Neoadjuvant chemotherapy plus surgery versus surgery for cervical cancer.新辅助化疗联合手术与单纯手术治疗宫颈癌的比较
Cochrane Database Syst Rev. 2012 Dec 12;12(12):CD007406. doi: 10.1002/14651858.CD007406.pub3.
4
Diagnostic performance of MRI for assessing axillary lymph node status after neoadjuvant chemotherapy in breast cancer: a systematic review and meta-analysis.MRI 评估乳腺癌新辅助化疗后腋窝淋巴结状态的诊断性能：系统评价和荟萃分析。
Eur Radiol. 2024 Feb;34(2):930-942. doi: 10.1007/s00330-023-10155-8. Epub 2023 Aug 24.
5
Neoadjuvant chemotherapy plus surgery versus surgery for cervical cancer.新辅助化疗联合手术与单纯手术治疗宫颈癌的比较
Cochrane Database Syst Rev. 2010 Jan 20(1):CD007406. doi: 10.1002/14651858.CD007406.pub2.
6
MRI and PET/CT for evaluation of the pathological response to neoadjuvant chemotherapy in breast cancer: A systematic review and meta-analysis.MRI 和 PET/CT 用于评估乳腺癌新辅助化疗的病理反应：系统评价和荟萃分析。
Breast. 2018 Aug;40:106-115. doi: 10.1016/j.breast.2018.04.018. Epub 2018 May 11.
7
A systematic overview of chemotherapy effects in breast cancer.乳腺癌化疗效果的系统综述。
Acta Oncol. 2001;40(2-3):253-81. doi: 10.1080/02841860151116349.
8
Neoadjuvant chemotherapy in locally advanced colon cancer: a systematic review and meta-analysis.局部晚期结肠癌的新辅助化疗：系统评价和荟萃分析。
Int J Colorectal Dis. 2021 Oct;36(10):2063-2070. doi: 10.1007/s00384-021-03945-3. Epub 2021 May 4.
9
The accuracy of F-FDG PET/CT in predicting the pathological response to neoadjuvant chemotherapy in patients with breast cancer: a meta-analysis and systematic review.F-FDG PET/CT 预测乳腺癌新辅助化疗病理反应的准确性：荟萃分析和系统评价。
Eur Radiol. 2017 Nov;27(11):4786-4796. doi: 10.1007/s00330-017-4831-y. Epub 2017 May 5.
10
Early prediction of pathologic response to neoadjuvant therapy in breast cancer: systematic review of the accuracy of MRI.早期预测乳腺癌新辅助治疗的病理反应：MRI 准确性的系统评价。
Breast. 2012 Oct;21(5):669-77. doi: 10.1016/j.breast.2012.07.006. Epub 2012 Aug 3.

引用本文的文献

1
Validation of a Quantitative Ultrasound Texture Analysis Model for Early Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer: A Prospective Serial Imaging Study.用于早期预测乳腺癌新辅助化疗反应的定量超声纹理分析模型的验证：一项前瞻性系列成像研究
Cancers (Basel). 2025 Aug 7;17(15):2594. doi: 10.3390/cancers17152594.

本文引用的文献

1
Tumor dormancy and relapse: understanding the molecular mechanisms of cancer recurrence.肿瘤休眠与复发：理解癌症复发的分子机制
Mil Med Res. 2025 Feb 11;12(1):7. doi: 10.1186/s40779-025-00595-2.
2
Physiological and tumor-associated angiogenesis: Key factors and therapy targeting VEGF/VEGFR pathway.生理性和肿瘤相关性血管生成：关键因素和针对 VEGF/VEGFR 通路的治疗方法。
Biomed Pharmacother. 2024 Nov;180:117585. doi: 10.1016/j.biopha.2024.117585. Epub 2024 Oct 22.
3
Association of peritumoral region features assessed on breast MRI and prognosis of breast cancer: a systematic review and meta-analysis.
基于乳腺 MRI 评估的肿瘤周围区域特征与乳腺癌预后的相关性：一项系统评价和荟萃分析。
Eur Radiol. 2024 Sep;34(9):6108-6120. doi: 10.1007/s00330-024-10612-y. Epub 2024 Feb 9.
4
Multiparametric MRI and Radiomics for the Prediction of HER2-Zero, -Low, and -Positive Breast Cancers.多参数 MRI 和放射组学在预测 HER2-零、低和阳性乳腺癌中的应用。
Radiology. 2023 Aug;308(2):e222646. doi: 10.1148/radiol.222646.
5
Angiogenic signaling pathways and anti-angiogenic therapy for cancer.血管生成信号通路与癌症的抗血管生成治疗。
Signal Transduct Target Ther. 2023 May 11;8(1):198. doi: 10.1038/s41392-023-01460-1.
6
Pathological angiogenesis: mechanisms and therapeutic strategies.病理性血管生成：机制与治疗策略。
Angiogenesis. 2023 Aug;26(3):313-347. doi: 10.1007/s10456-023-09876-7. Epub 2023 Apr 15.
7
Regulation of Metastatic Tumor Dormancy and Emerging Opportunities for Therapeutic Intervention.调控转移性肿瘤休眠及治疗干预新契机
Int J Mol Sci. 2022 Nov 11;23(22):13931. doi: 10.3390/ijms232213931.
8
MRI can accurately diagnose breast cancer during lactation.MRI 可准确诊断哺乳期乳腺癌。
Eur Radiol. 2023 Apr;33(4):2935-2944. doi: 10.1007/s00330-022-09234-z. Epub 2022 Nov 8.
9
A concise review of VEGF, PDGF, FGF, Notch, angiopoietin, and HGF signalling in tumor angiogenesis with a focus on alternative approaches and future directions.简要综述了 VEGF、PDGF、FGF、Notch、血管生成素和 HGF 在肿瘤血管生成中的信号通路，并重点探讨了肿瘤血管生成的其他治疗方法和未来研究方向。
Int J Biol Macromol. 2022 Nov 30;221:1428-1438. doi: 10.1016/j.ijbiomac.2022.09.129. Epub 2022 Sep 17.
10
The impact of VEGF on cancer metastasis and systemic disease.VEGF 对癌症转移和全身疾病的影响。
Semin Cancer Biol. 2022 Nov;86(Pt 3):251-261. doi: 10.1016/j.semcancer.2022.03.011. Epub 2022 Mar 17.